Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-002981-29Phase 4Active
Phase 4 trial of prednisone in chondrocalcinosis (CPPD), sponsored by Groupement des Hôpitaux de l'Institut Catholique de Lille. Started Jun 2017; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-002981-29.